Baloxavir Marboxil Treatment of Nude Mice Infected With Influenza A Virus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31837268.
- Also identified by DOI 10.1093/infdis/jiz665 and PMC identifier 7184910.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immunocompromised patients infected with influenza virus require prolonged treatment with neuraminidase inhibitors, because these patients are not able to eradicate the virus from the respiratory tract, leading to the emergence of drug-resistant mutant viruses. In this study, we examined the efficacy of baloxavir marboxil in nude mice that were immunologically deficient. Daily treatment with a suboptimal dose of baloxavir marboxil increased the survival time of the virus-infected nude mice but did not clear the virus from their respiratory organs, resulting in gradual body weight loss after termination of treatment. Despite the prolonged baloxavir marboxil treatment, few resistant mutants were detected.
Medical subject headings
- Antiviral Agents
- Dibenzothiepins
- Influenza A virus
- Morpholines
- Orthomyxoviridae Infections
- Pyridones
- Triazines